EP
Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ·Healthcare·Biotechnology
$6.48
-0.46%
Mkt Cap $222.64M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$19.00
Range $19.00 – $19.00
Implied Upside
+193.2%
Consensus $19.00 vs current $6.48
NASDAQ·Healthcare·Biotechnology
$6.48
-0.46%
Mkt Cap $222.64M
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$19.00
Range $19.00 – $19.00
+193.2%
Consensus $19.00 vs current $6.48